329 related articles for article (PubMed ID: 20389090)
21. Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes.
Pitteloud N; Meysing A; Quinton R; Acierno JS; Dwyer AA; Plummer L; Fliers E; Boepple P; Hayes F; Seminara S; Hughes VA; Ma J; Bouloux P; Mohammadi M; Crowley WF
Mol Cell Endocrinol; 2006 Jul; 254-255():60-9. PubMed ID: 16764984
[TBL] [Abstract][Full Text] [Related]
22. PROKR2 missense mutations associated with Kallmann syndrome impair receptor signalling activity.
Monnier C; Dodé C; Fabre L; Teixeira L; Labesse G; Pin JP; Hardelin JP; Rondard P
Hum Mol Genet; 2009 Jan; 18(1):75-81. PubMed ID: 18826963
[TBL] [Abstract][Full Text] [Related]
23. Kallmann syndrome in women: from genes to diagnosis and treatment.
Meczekalski B; Podfigurna-Stopa A; Smolarczyk R; Katulski K; Genazzani AR
Gynecol Endocrinol; 2013 Apr; 29(4):296-300. PubMed ID: 23368665
[TBL] [Abstract][Full Text] [Related]
24. Congenital hypogonadotropic hypogonadism in females: clinical spectrum, evaluation and genetics.
Bry-Gauillard H; Trabado S; Bouligand J; Sarfati J; Francou B; Salenave S; Chanson P; Brailly-Tabard S; Guiochon-Mantel A; Young J
Ann Endocrinol (Paris); 2010 May; 71(3):158-62. PubMed ID: 20363464
[TBL] [Abstract][Full Text] [Related]
25. [GnRH deficiency: new insights from genetics].
Kottler ML; Hamel A; Malville E; Richard N
J Soc Biol; 2004; 198(1):80-7. PubMed ID: 15146960
[TBL] [Abstract][Full Text] [Related]
26. [Hypogonadotropic hypogonadism: new aspects in the regulation of hypothalamic-pituitary-gonadal axis].
Brioude F; Bouvattier CE; Lombès M
Ann Endocrinol (Paris); 2010 Sep; 71 Suppl 1():S33-41. PubMed ID: 21237329
[TBL] [Abstract][Full Text] [Related]
27. Biallelic PROKR2 variants and congenital hypogonadotropic hypogonadism: a case report and a literature review.
Sugisawa C; Taniyama M; Sato T; Takahashi Y; Hasegawa T; Narumi S
Endocr J; 2022 Jul; 69(7):831-838. PubMed ID: 35236788
[TBL] [Abstract][Full Text] [Related]
28. Mutation analyses in pedigrees and sporadic cases of ethnic Han Chinese Kallmann syndrome patients.
Gu WJ; Zhang Q; Wang YQ; Yang GQ; Hong TP; Zhu DL; Yang JK; Ning G; Jin N; Chen K; Zang L; Wang AP; Du J; Wang XL; Yang LJ; Ba JM; Lv ZH; Dou JT; Mu YM
Exp Biol Med (Maywood); 2015 Nov; 240(11):1480-9. PubMed ID: 26031747
[TBL] [Abstract][Full Text] [Related]
29. Kallmann syndrome.
Dodé C; Hardelin JP
Eur J Hum Genet; 2009 Feb; 17(2):139-46. PubMed ID: 18985070
[TBL] [Abstract][Full Text] [Related]
30. The genetic and molecular basis of idiopathic hypogonadotropic hypogonadism.
Bianco SD; Kaiser UB
Nat Rev Endocrinol; 2009 Oct; 5(10):569-76. PubMed ID: 19707180
[TBL] [Abstract][Full Text] [Related]
31. Eight rare urinary disorders in a patient with Kallmann syndrome: A case report.
Tian H; Yan Z; Lv Y; Sun L; Gang X; Wang G
Medicine (Baltimore); 2020 Oct; 99(43):e22936. PubMed ID: 33120852
[TBL] [Abstract][Full Text] [Related]
32. PROKR2 mutations in autosomal recessive Kallmann syndrome.
Tommiska J; Toppari J; Vaaralahti K; Känsäkoski J; Laitinen EM; Noisa P; Kinnala A; Niinikoski H; Raivio T
Fertil Steril; 2013 Mar; 99(3):815-8. PubMed ID: 23200691
[TBL] [Abstract][Full Text] [Related]
33. [Congenital hypogonadotropic hypogonadism and Kallmann syndrome in males].
Ghervan C; Young J
Presse Med; 2014 Feb; 43(2):152-61. PubMed ID: 24456696
[TBL] [Abstract][Full Text] [Related]
34. Identification of two novel missense mutations in the KAL1 gene in Han Chinese subjects with Kallmann Syndrome.
Jap TS; Chiu CY; Lirng JF; Won GS
J Endocrinol Invest; 2011 Jan; 34(1):53-9. PubMed ID: 20530987
[TBL] [Abstract][Full Text] [Related]
35. Kallmann syndrome with a Tyr113His PROKR2 mutation.
Ha JH; Lee S; Kim Y; Moon JI; Seo J; Jang JH; Cho EH; Kim JM; Rhee BD; Ko KS; Yoo SJ; Won JC
Medicine (Baltimore); 2017 Sep; 96(35):e7974. PubMed ID: 28858133
[TBL] [Abstract][Full Text] [Related]
36. Congenital Hypogonadotropic Hypogonadism with Anosmia and Gorlin Features Caused by a PTCH1 Mutation Reveals a New Candidate Gene for Kallmann Syndrome.
Barraud S; Delemer B; Poirsier-Violle C; Bouligand J; Mérol JC; Grange F; Higel-Chaufour B; Decoudier B; Zalzali M; Dwyer AA; Acierno JS; Pitteloud N; Millar RP; Young J
Neuroendocrinology; 2021; 111(1-2):99-114. PubMed ID: 32074614
[TBL] [Abstract][Full Text] [Related]
37. Genetic insights into human isolated gonadotropin deficiency.
Trarbach EB; Silveira LG; Latronico AC
Pituitary; 2007; 10(4):381-91. PubMed ID: 17624596
[TBL] [Abstract][Full Text] [Related]
38. Clinical genetics of Kallmann syndrome.
Dodé C; Hardelin JP
Ann Endocrinol (Paris); 2010 May; 71(3):149-57. PubMed ID: 20362962
[TBL] [Abstract][Full Text] [Related]
39. Pleiotropic effects of prokineticin 2 in the control of energy metabolism.
Magnan C; Migrenne-Li S
Biochimie; 2021 Jul; 186():73-81. PubMed ID: 33932486
[TBL] [Abstract][Full Text] [Related]
40. [Clinical and molecular aspects of congenital isolated hypogonadotropic hypogonadism].
Tusset C; Trarbach EB; Silveira LF; Beneduzzi D; Montenegro L; Latronico AC
Arq Bras Endocrinol Metabol; 2011 Nov; 55(8):501-11. PubMed ID: 22218430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
